Display options
Cite
Rascol O, Hain TC, Brefel C, et al. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs. 1995;50(5):777-91doi: 10.2165/00003495-199550050-00002.
Rascol, O., Hain, T. C., Brefel, C., Benazet, M., Clanet, M., & Montastruc, J. L. (1995). Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs, 50(5), 777-91. https://doi.org/10.2165/00003495-199550050-00002
Rascol, O, et al. "Antivertigo medications and drug-induced vertigo. A pharmacological review." Drugs vol. 50,5 (1995): 777-91. doi: https://doi.org/10.2165/00003495-199550050-00002
Rascol O, Hain TC, Brefel C, Benazet M, Clanet M, Montastruc JL. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs. 1995 Nov;50(5):777-91. doi: 10.2165/00003495-199550050-00002. PMID: 8586026.
Copy Download .nbib Format: NLM
Share it on
Full text links
Springer

Drugs. 1995 Nov;50(5):777-91. doi: 10.2165/00003495-199550050-00002.

Antivertigo medications and drug-induced vertigo. A pharmacological review.

Drugs

O Rascol, T C Hain, C Brefel, M Benazet, M Clanet, J L Montastruc

Affiliations

  1. Laboratory of Medical and Clinical Pharmacology, Faculty of Medicine, Toulouse, France.

PMID: 8586026 DOI: 10.2165/00003495-199550050-00002

Abstract

The approach to drug treatment of vertigo is almost exclusively symptomatic. There are 3 major goals for drug treatment of vertigo. The first one is to eliminate the hallucination of motion. Drugs with vestibular 'suppressant' properties are used for this purpose. The major vestibular suppressants are anticholinergic and antihistamine drugs. The second goal is to reduce the accompanying neurovegetative and psychoaffective signs (nausea, vomiting, anxiety). Antidopaminergics are used for this purpose. The third goal is to enhance the process of 'vestibular compensation' to allow the brain to find a new sensory equilibrium in spite of the vestibular lesion. Until now, the pharmacological manipulation of vestibular compensation has been assessed in animals but not in humans with vestibular lesions. Vestibular suppressant drugs delay rather than enhance compensation. A variety of other drugs is also used in the treatment of vertigo, including benzodiazepines, histaminergic agents, sympathomimetics and calcium antagonists. Their mechanism of action is poorly understood. The data base derived from clinical trials evaluating antivertigo medications is often questionable because of methodological limitations. This explains why habits of prescription are mainly empirical, and why striking differences can be noticed from one country to another. We can hope that new treatments may emerge from the present interest in receptor subclasses and neuromodulators of the vestibular system, and we must be ready to evaluate these potential new pharmacological agents with reliable clinical methods in humans.

Cited by

References

  1. Prog Brain Res. 1992;90:307-31 - PubMed
  2. Drugs. 1988 Dec;36(6):754-72 - PubMed
  3. Am J Otolaryngol. 1986 May-Jun;7(3):177-80 - PubMed
  4. Drug Saf. 1993 Aug;9(2):143-8 - PubMed
  5. Clin Neuropharmacol. 1988 Jun;11(3):232-40 - PubMed
  6. Stroke. 1981 Jan-Feb;12(1):111-4 - PubMed
  7. Arch Otolaryngol Head Neck Surg. 1987 May;113(5):536-42 - PubMed
  8. C R Seances Soc Biol Fil. 1957;151(7):1365-7 - PubMed
  9. Neurology. 1976 Sep;26(9):818-20 - PubMed
  10. Ann Neurol. 1994 Mar;35(3):319-25 - PubMed
  11. Drugs. 1984 Jan;27(1):6-44 - PubMed
  12. J Clin Pharmacol. 1974 May-Jun;14(5-6):280-9 - PubMed
  13. Epilepsia. 1988 Nov-Dec;29(6):787-93 - PubMed
  14. Proc R Soc Med. 1952 Jun;45(6):341-54 - PubMed
  15. Drugs. 1991 Apr;41(4):574-95 - PubMed
  16. J Clin Pharmacol. 1992 Nov;32(11):1008-12 - PubMed
  17. Arch Neurol. 1989 Mar;46(3):281-4 - PubMed
  18. Drugs. 1979 Jun;17(6):471-9 - PubMed
  19. Laryngoscope. 1986 Aug;96(8):878-98 - PubMed
  20. Br J Pharmacol. 1994 Jan;111(1):358-63 - PubMed
  21. Brain Res Brain Res Rev. 1989 Apr-Jun;14(2):155-80 - PubMed
  22. Neurology. 1987 Mar;37(3):371-8 - PubMed
  23. Pharmacol Biochem Behav. 1993 Jan;44(1):99-105 - PubMed
  24. Eur J Pharmacol. 1989 Dec 19;174(2-3):273-8 - PubMed
  25. Arch Neurol. 1972 Aug;27(2):129-35 - PubMed
  26. Trans Am Acad Ophthalmol Otolaryngol. 1959 Mar-Apr;63(2):206-18 - PubMed
  27. Fundam Clin Pharmacol. 1994;8(4):293-306 - PubMed
  28. Acta Otolaryngol Suppl. 1991;479:5-11 - PubMed
  29. Trends Neurosci. 1989 Apr;12(4):148-51 - PubMed
  30. Arch Ital Biol. 1993 Apr;131(2-3):159-71 - PubMed
  31. Brain Res. 1980 Aug 18;195(2):476-8 - PubMed
  32. Behav Brain Res. 1987 Feb;23(2):117-26 - PubMed
  33. Neurology. 1989 Mar;39(3):432-3 - PubMed
  34. J Neurol Neurosurg Psychiatry. 1983 Aug;46(8):716-24 - PubMed
  35. Am J Otolaryngol. 1985 Jul-Aug;6(4):290-6 - PubMed
  36. Clin Neuropharmacol. 1986;9(4):311-28 - PubMed
  37. Neurology. 1994 May;44(5):796-800 - PubMed
  38. Epilepsia. 1971 Jun;12(2):157-64 - PubMed
  39. Arch Ital Biol. 1989 Oct;127(4):243-63 - PubMed
  40. Arch Otolaryngol. 1985 Sep;111(9):609-12 - PubMed
  41. J Vestib Res. 1995 Jan-Feb;5(1):53-66 - PubMed
  42. Eur J Neurosci. 1995 Apr 1;7(4):555-62 - PubMed
  43. Ann Neurol. 1980 Jan;7(1):18-23 - PubMed
  44. Brain Res. 1988 Oct 4;461(2):282-9 - PubMed
  45. Neurosci Lett. 1988 Dec 5;94(3):309-13 - PubMed
  46. Acta Otolaryngol Suppl. 1991;490:1-10 - PubMed
  47. Clin Pharmacol Ther. 1994 Jun;55(6):670-80 - PubMed
  48. Postgrad Med. 1983 May;73(5):317-24 - PubMed
  49. Drugs. 1985 Sep;30(3):275-83 - PubMed
  50. Br J Audiol. 1982 May;16(2):81-93 - PubMed
  51. Aviat Space Environ Med. 1986 Jan;57(1):45-8 - PubMed
  52. Laryngoscope. 1991 Feb;101(2):211-8 - PubMed
  53. Presse Med. 1952 Feb 13;60(10):206-8 - PubMed
  54. Fundam Clin Pharmacol. 1989;3 Suppl:79s-87s - PubMed
  55. Acta Neurol Scand. 1989 Feb;79(2):128-32 - PubMed
  56. Acta Otolaryngol. 1983 Nov-Dec;96(5-6):389-95 - PubMed
  57. Brain Res. 1981 Oct 19;222(2):458-62 - PubMed
  58. Clin Pharmacol Ther. 1981 Mar;29(3):414-9 - PubMed
  59. Arch Otorhinolaryngol. 1982;236(3):229-36 - PubMed
  60. Acta Otolaryngol Suppl. 1994;513:28-32 - PubMed
  61. Am J Psychiatry. 1986 Oct;143(10):1227-33 - PubMed
  62. J Physiol. 1987 Dec;393:703-25 - PubMed
  63. Lancet. 1995 May 6;345(8958):1182-3 - PubMed
  64. J Vestib Res. 1992;2(1):31-9 - PubMed
  65. Presse Med. 1986 Sep 25;15(31):1569-72 - PubMed
  66. Brain Res. 1986 Jan 29;364(1):190-4 - PubMed
  67. Laryngoscope. 1977 Nov;87(11):1870-7 - PubMed
  68. ORL J Otorhinolaryngol Relat Spec. 1974;36(3):157-64 - PubMed
  69. Neurosci Lett. 1990 Oct 2;118(1):14-6 - PubMed
  70. Neuroscience. 1988 Aug;26(2):553-600 - PubMed
  71. J Laryngol Otol. 1980 Sep;94(9):1009-15 - PubMed
  72. Pharmacol Biochem Behav. 1992 Aug;42(4):595-604 - PubMed
  73. Eur J Pharmacol. 1985 Apr 23;111(1):73-84 - PubMed
  74. Acta Otolaryngol Suppl. 1984;419:62-70 - PubMed
  75. Brain Res Brain Res Rev. 1995 Jan;20(1):24-46 - PubMed
  76. Acta Otolaryngol. 1977 Nov-Dec;84(5-6):317-27 - PubMed
  77. Aerosp Med. 1974 Oct;45(10):1177-9 - PubMed
  78. Am J Otolaryngol. 1989 Sep-Oct;10(5):351-9 - PubMed
  79. Brain Res. 1987 Jul 21;416(1):22-33 - PubMed
  80. Acta Otolaryngol Suppl. 1988;460:72-9 - PubMed
  81. Acta Otolaryngol Suppl. 1992;497:1-189 - PubMed
  82. Arch Ital Biol. 1993 Apr;131(2-3):173-90 - PubMed
  83. Brain Res Brain Res Rev. 1991 May-Aug;16(2):117-33 - PubMed
  84. Drugs. 1982 Nov;24(5):360-400 - PubMed
  85. Ann Neurol. 1993 Nov;34(5):694-702 - PubMed
  86. Arch Otolaryngol. 1980 Aug;106(8):484-5 - PubMed
  87. Prog Brain Res. 1988;76:29-43 - PubMed

MeSH terms

Publication Types

LinkOut - more resources